Charlotte D. Jacobs M.D.

Publications

• A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC). Wakelee HA, Middleton G, Dunlop D, Ramlau R, Leighl N, Hao D, Lopez-Anaya A, Zatloukal P, Jacobs CD. Cancer Chemother Pharmacol. 2012; 69 (3): 815-24
• The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer. Wakelee HA, Takimoto CH, Lopez-Anaya A, Chu Q, Middleton G, Dunlop D, Ramlau R, Leighl N, Rowinsky EK, Hao D, Zatloukal P, Jacobs CD, Rodon J. Cancer Chemother Pharmacol. 2012; 69 (2): 563-71
• Antiangiogenesis agents in the treatment of soft tissue sarcomas. Ganjoo K, Jacobs C. Cancer. 2010; 116 (5): 1177-83
• Acute myeloid leukemia in patients with gastrointestinal stromal tumors treated with Gleevec. Ganjoo KN, Demetri GD, Jacobs C, Patel S. Leuk Lymphoma. 2009; 50 (11): 1882-4
• Breast Angiosarcoma: Case Series and Expression of Vascular Endothelial Growth Factor. Brar R, West R, Witten D, Raman B, Jacobs C, Ganjoo K. Case Rep Oncol. 2009; 2 (3): 242-250
• The value of surgery for retroperitoneal sarcoma. Gholami S, Jacobs CD, Kapp DS, Parast LM, Norton JA. Sarcoma. 2009: 2009 605840
• Tamoxifen for salivary gland adenoid cystic carcinoma: report of two cases. Elkin AD, Jacobs CD. J Cancer Res Clin Oncol. 2008; 134 (10): 1151-3
• Primary paraspinal leiomyosarcoma invading the cervical spinal canal successfully treated with surgery, radiotherapy, and chemotherapy. Case report. Lehman NL, Jacobs CD, Holsten PA, Jaikumar S, Lehman TD, Gibbs IC, Shuer LM. J Neurosurg Spine. 2007; 6 (5): 441-6
• A phase I trial of liposomal doxorubicin, paclitaxel and valspodar (PSC-833), an inhibitor of multidrug resistance. Advani R, Lum BL, Fisher GA, Halsey J, Chin DL, Jacobs CD, Sikic BI. Ann Oncol. 2005; 16 (12): 1968-73
• Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report. Nguyen DD, Loo BW, Tillman G, Natkunam Y, Cao TM, Vaughan W, Dorfman RF, Goffinet DR, Jacobs CD, Advani RH. Ann Hematol. 2003; 82 (8): 521-5
• Impact of a program to diminish gender insensitivity and sexual harassment at a medical school. Jacobs CD, Bergen MR, Korn D. Acad Med. 2000; 75 (5): 464-9
• Lymphomas of the head and neck. Yuen A, Jacobs C. Semin Oncol. 1999; 26 (3): 338-45
• Outcome measurement in postgraduate year one of graduates from a medical school with a pass/fail grading system. Vosti KL, Jacobs CD. Acad Med. 1999; 74 (5): 547-9
• Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy. Hausdorff J, Davis E, Long G, Hoppe R, van der Pas M, Lassman C, Kamel O, Jacobs C. Cancer J Sci Am. 1997 Sep-Oct; 3 (5): 303-11
• The relationship of clinical knowledge to months of clinical training among medical students. Vosti KL, Bloch DA, Jacobs CD. Acad Med. 1997; 72 (4): 305-7
• A climate survey for medical students. A means to assess change. Bergen MR, Guarino CM, Jacobs CD. Eval Health Prof. 1996; 19 (1): 30-47
• A multicenter maintenance study of oral pilocarpine tablets for radiation-induced xerostomia. Jacobs CD, van der Pas M. Oncology (Williston Park). 1996; 10 (3 Suppl): 16-20
• Status of the Medical Oncology Workforce Mayer RJ, Antman KH, Bailes JS, Bloomfield CD, Canellos GP, Glick JG, Jacobs CJ. Journal of Clinical Oncology. 1996; 14 (9): 2612-2621.
• A multimodality approach to preparation for clinical medicine. Jacobs C, Moreno B, Blaschke T. Acad Med. 1995; 70 (5): 441-2
• A sexual harassment workshop for medical students. Jacobs C, Bergen M. Acad Med. 1995; 70 (5): 434-5
• Adjuvant and neoadjuvant treatment of head and neck cancers: the next chapter. Jacobs C, Pinto H. Semin Oncol. 1995; 22 (6): 540-52
• Adjuvant and neoadjuvant treatment of head and neck cancers: the next chapter. Jacobs CJ, Pinto H.. Seminars in Oncology.. 1995; 22 (6): 540-52.
• Distant metastases from head and neck squamous cancer: the role of adjuvant chemotherapy. Pinto HA, Jacobs C. Cancer Treat Res. 1995: 74 243-62
• Head and neck cancer - combined modality therapy and chemotherapy. Pinto HA, Jacobs C. Brian MC and Carbone PP (eds), Current Therapy in Hematology-Oncology, Mosby, St. Louis,. 1995: 352-358.
• Head and neck cancers Jacobs C, Pinto HA. Macdonald JS, Haller DG, Mayer RJ (eds), Manual of Oncologic Therapeutics, Third Edition, JB Lippincott, Philadelphia. 1995: 162-169.
• The value of medical student research: the experience at Stanford University School of Medicine. Jacobs CD, Cross PC. Med Educ. 1995; 29 (5): 342-6
• A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. Jacobs C, Lyman G, Velez-García E, Sridhar KS, Knight W, Hochster H, Goodnough LT, Mortimer JE, Einhorn LH, Schacter L. J Clin Oncol. 1992; 10 (2): 257-63
• Adjuvant and neoadjuvant treatment of head and neck cancers. Jacobs C, Semin Oncol. 1991; 18 (6): 504-14
• Chemotherapy for recurrent and metastatic head and neck cancer. Pinto HA, Jacobs C. Hematol Oncol Clin North Am. 1991; 5 (4): 667-86
• The use of probenecid as a chemoprotector against cisplatin nephrotoxicity. Jacobs C, Kaubisch S, Halsey J, Lum BL, Gosland M, Coleman CN, Sikic BI. Cancer. 1991; 67 (6): 1518-24
• Head and neck squamous cancers. Jacobs CD, Goffinet DR, Fee WE. Curr Probl Cancer. 1990 Jan-Feb; 14 (1): 1-72
• A phase II trial of carbetimer for the treatment of colorectal cancer. A trial of the Northern California Oncology Group. Audeh MW, Jacobs CD, Davis TE, Carlson RW. Am J Clin Oncol. 1990; 13 (4): 324-6
• Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the Head and Neck Contracts Program. Jacobs C, Makuch R. J Clin Oncol. 1990; 8 (5): 838-47
• Modification of cisplatin toxicity with diethyldithiocarbamate. Berry JM, Jacobs C, Sikic B, Halsey J, Borch RF. J Clin Oncol. 1990; 8 (9): 1585-90
• The internist in the management of head and neck cancer. Jacobs C, Ann Intern Med. 1990; 113 (10): 771-8
• Adjuvant chemotherapy for head and neck cancer. Jacobs C, J Clin Oncol. 1989; 7 (7): 823-6